Syngene listing not now
The market meltdown has put paid to one more listing plan for now: that of Biocon’s custom research subsidiary, Syngene International, reports The Hindu Business Line.
The market meltdown has put paid to one more listing plan for now: that of Biocon’s custom research subsidiary, Syngene International, reports The Hindu Business Line.